News and Trends 26 Feb 2018 This Oral Vaccine for Typhoid Raises €8M from International Investors Prokarium has raised $10M (€8M) from Saudi, Swedish and Korean investors to support the clinical development of its oral vaccines for infectious diseases like typhoid. Since its foundation in 2012, Prokarium has been working on oral vaccines and it has developed a delivery platform that can be applied to any antigen used for vaccination. The biotech has […] February 26, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
Interview 26 Feb 2018 This Biotech Could Replace Opioids with Safe and Effective Pain Relief for Osteoarthritis The use of opioids and non-steroidal anti-inflammatory drugs (NSAIDs) is a massive public health issue. I spoke with Simon Westbrook, CEO of Levicept, whose new approach to pain relief, which is being tested for osteoarthritis, could be a game-changer. Back in September, a couple of weeks into my time at Labiotech, I got the chance […] February 26, 2018 - 9 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
More News! 24 Feb 2018 The First and Only Museum of Microbes Captivates Amsterdam Micropia, a museum of microbes located in the heart of Amsterdam, uses art to address the big knowledge gap between science and the general public. Microbiology originated just a few kilometers from Amsterdam when Antoni van Leeuwenhoek built one of the first microscopes and discovered that everyday objects, as well as himself, were teeming with minuscule forms of life. More […] February 24, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 23 Feb 2018 Novo Nordisk Gets Close to Launching the First Oral GLP-1 Drug for Diabetes Novo Nordisk has positive Phase III trial results for its oral version of semaglutide, a GLP-1 based treatment for type II diabetes. This could be the first oral GLP-1 treatment on the market, making it easier for patients to take the drug. After obtaining approval for an injected version, Novo Nordisk is now getting ready […] February 23, 2018 - 3 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 23 Feb 2018 Crack Open the Champagne, AiCuris’ Antiviral Launched in Germany Update (23/02/2018): Merck Sharp & Dohme (MSD), licensee of AiCuris, has launched letermovir in Germany under the trade name Prevymis. The antiviral drug will be available to patients undergoing a hematopoietic stem cell transplant (HSCT) to prevent reactivation of latent human cytomegalovirus (CMV), which can prove lethal in the weakened state of this patients. Update (31/01/2018): […] February 23, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 22 Feb 2018 GW Pharma’s Latest Cannabinoid Drug Pegged Back by a Placebo in Phase II One of GW Pharma’s cannabinoid drugs for epilepsy has suffered a set back in a Phase IIa trial as a placebo matched its capacity to reduce the frequency of focal seizures. GW Pharma wants to use cannabinoid drugs to treat conditions like autism and epilepsy. However, one of its drug candidates, GWP42006, has slipped up in a Phase […] February 22, 2018 - 2 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 22 Feb 2018 Bacteria-Killing Viruses Could Stop You From Getting Food Poisoning A group of Finnish scientists has demonstrated that phage could be used to prevent food poisoning by killing dangerous foodborne pathogens like Yersinia enterocolitica. Researchers at the University of Helsinki believe that bacteria-killing viruses called phage could be more than just an alternative to antibiotics and a solution to the growing antibiotic resistance crisis. A study, published […] February 22, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 22 Feb 2018 You Will Soon Be Able To Paint With Bacteria! Researchers in the UK and the Netherlands have unlocked the genetic code that changes the color of certain bacteria. The discovery could lead to large-scale manufacturing of biodegradable, non-toxic paint. In a collaborative study between the University of Cambridge and the Dutch company Hoekmine, researchers compared the genetic information of certain bacterial colonies to their […] February 22, 2018 - 3 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
Interview 22 Feb 2018 Could a New Approach Help Us to Overcome Resistance to HIV Treatment? Clara chatted with Christian Setz, CEO of Immunologik, to find out how the company is developing a new HIV treatment that could overcome resistance to anti-retroviral drugs. Over 36 million people are living with human immunodeficiency virus (HIV), which has led to many biotechs, including Abivax, working on better options for patients. Immunologik, a recent ‘Biotech of the Week’, is […] February 22, 2018 - 4 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 21 Feb 2018 Implantation of Carmat’s Artificial Heart Begins in Denmark to Beat Low Enrolment Carmat’s artificial heart is being tested in patients with heart failure. A hospital in Copenhagen will implant the device, which the biotech hopes will boost patient enrolment to its PIVOTAL trial. Carmat has developed the world’s most advanced fully artificial heart, which has been designed for patients suffering from end-stage biventricular heart failure. The biotech has […] February 21, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 21 Feb 2018 FDA Approves AstraZeneca’s Lung Cancer Treatment after Rejecting Merck and Pfizer’s The FDA approval will give AstraZeneca a competitive advantage in the lung cancer treatment market over Merck KGaA & Pfizer, who received rejections for a similar treatment. AstraZeneca received FDA approval for Imfinzi in non-small cell lung cancer one day after Merck KgA and Pfizer received a rejection for competitor drug Bavencio in the same indication. Imfinzi (durvalumab) […] February 21, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 21 Feb 2018 Early Autism Diagnosis Could be Possible With New Blood and Urine Tests The detection of damaged proteins in blood and urine tests could help to diagnose autism quicker so that children can be given appropriate treatment. Researchers at the University of Warwick have developed new blood and urine tests that detect damaged proteins, which are associated with autism spectrum disorders. The study, published in Molecular Autism, explains how […] February 21, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email